Reportedly, the oral weight loss pill VK2735 showed promising signs of effectiveness and a tolerable safety profile.
Viking Therapeutics Reveals Positive Results from Oral Obesity Drug
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours